URIT

What URIT does

URIT (桂林优利特医疗电子有限公司), founded in 1984 and headquartered in Guilin, China, is a privately held in-vitro diagnostics (IVD) manufacturer that pioneered China's first domestically produced urine analyzer and has since expanded into a ten-product-line portfolio spanning urine analysis, hematology, biochemistry and immunoassay, point-of-care testing, flow cytometry, immune and gene diagnostics (PCR, NGS library prep, Sanger sequencing), pathology staining, gynecological diagnostics, and AI-powered smart laboratory solutions. Its technology stack combines proprietary hardware (four-angle laser scattering hematology, SBS slide transmission for HE stainers, three-laser flow cytometry) with deep learning computer vision applied to urine sediment, blood cell morphology, and vaginal secretion analysis, plus an in-house LIS platform integrated with hospital EMR/EHR systems via HL7. The business model rests on three reinforcing revenue streams: one-time hardware sales of analyzers, recurring reagent and consumable sales tied to the installed base, and software/services (UriLab, LIS, technical support across 400+ domestic and 70+ international service centers), sold through a hybrid channel of direct enterprise sales for major hospitals, regional distributors in China, and an international distributor network reaching 180+ countries.

URIT holds a comprehensive global compliance footprint — FDA 510(k) on the UC-1800, CE, IVDR, ISO 13485/14001, ICSH membership, JCTLM reference measurement listing, and IECEE CTF TÜV SÜD accreditation — supporting a customer base of more than one million healthcare institutions. Customer concentration is low and geographically diversified across Europe, Americas, Africa, Middle East, CIS, and Asia, with named anchor deployments such as Russia's largest public laboratory running eight US-2000 AI modular urinalysis units at 7,000+ samples daily. Recent strategic emphasis has shifted from purely domestic IVD competition toward standards-body participation (ICSH, IFCC) and ecosystem platform plays, including the 2025 launch of UriLab and a 2026 brand renewal and global ecosystem strategy. AI capabilities are differentiated within urine and vaginal secretion analysis (US-2000 series CNN-based recognition of 38+ parameters; SL-1000 >90% recognition rate) but uneven across the portfolio, positioning URIT as a category-leading Chinese IVD exporter transitioning from a hardware-centric manufacturer into an integrated diagnostics platform provider.

Name

URIT

Legal name

桂林优利特医疗电子有限公司

Website

https://urit.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

1–10 employees

Short description

URIT is a privately held Chinese IVD manufacturer founded in 1984, producing urine, hematology, biochemistry, flow cytometry, POCT, and AI-powered laboratory systems sold across 180+ countries to over one million healthcare institutions, with recurring reagent revenue and an expanding smart-lab software platform.

Ownership category

akta.pro rank

Product category

In-vitro Diagnostics (IVD) Medical Equipment

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Urinalysis & Routine Screening Diagnostics (HLAHAAAG), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), General Urology (HLAKAOAA)

Keywords

• In-vitro diagnostics
• Medical diagnostic equipment
• Clinical laboratory automation
• Urine analysis systems
• Hematology analyzers

Headquarters

HQ city

Guilin

HQ country

China

HQ region

Asia

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D

Revenue model

1. Medical Diagnostic Equipment Sales: Sale of IVD equipment including urinalysis systems, hematology analyzers, biochemistry analyzers, POCT devices, flow cytometers, and other diagnostic instruments to healthcare facilities globally
2. Diagnostic Reagents and Consumables: 配套试剂、试纸条及其他耗材的销售, providing continuous revenue from reagent sales for installed equipment base
3. Laboratory Information System (LIS) Software: URIT LIS software solutions for laboratory information management, including standalone versions for grassroots medical institutions and enterprise versions for large hospitals
4. Technical Services and Support: After-sales technical support, installation, training, and maintenance services through extensive service network of 400+ domestic centers and 70+ international designated centers

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

URIT manufactures and sells in-vitro diagnostic (IVD) medical equipment and reagents across ten product lines, including urine analysis systems, blood cell analyzers, biochemical and immunoassay analyzers, POCT devices, flow cytometers, veterinary diagnostic instruments, pathology stainers, gynecological analyzers, and gene/immune diagnostic reagents. The portfolio is anchored by AI-powered modular diagnostic platforms (e.g., US-2000, US-5000, UriLab) and complemented by the URIT Laboratory Information System (LIS) software. Products are sold to hospital clinical laboratories, grassroots medical institutions, research institutions, and veterinary clinics in 180+ countries.

Product overview

URIT (桂林优利特医疗电子有限公司) is a leading Chinese in-vitro diagnostics (IVD) manufacturer offering a comprehensive portfolio of medical diagnostic products across 10 major product lines. The product ecosystem is organized as a platform-plus-modules architecture centered on AI-powered laboratory solutions. The core offerings include: Urine Analysis Systems (US-2000 series AI modular urine analysis pipeline, US-5000 full detection chain production line, US-1000 series); Blood Cell Analysis Systems (BS-8000 Kunlun series blood analysis pipeline, BS-7000 series, BH-6000 series hematology analyzers); Biochemical Immunoassay Systems (CA-2000 series high-speed biochemical analyzers, URIT-8300, CA-400/800 series); POCT Diagnostic Products (PD-92 dry biochemical analyzer, hemoglobin analyzers); Veterinary Diagnostics (US-500Vet urine analysis, URIT-8400Vet/CA-810CVet biochemistry); Flow Cytometry (BF-700/710/730 series); Immune and Gene Diagnostics (PCR reagents, NGS library construction, Sanger sequencing); Pathology Diagnosis (MS-3000/9300 HE stainers); Gynecological Diagnosis (SL-1000/SL-50 vaginal secretion analyzers); and AI Smart Laboratory solutions (UriLab). These products are supported by the URIT LIS (Laboratory Information Management System) and hospital glucose management system for integrated data management. The portfolio spans from high-throughput laboratory automation to point-of-care testing, with AI integration across urine, blood, and vaginal secretion analysis systems.

Differentiator

Problem solved

Functional benefit

Brands

• UriLab: URIT Smart Laboratory Solution — AI-powered laboratory information management and automation solution for smart diagnostics.
• BF Series
• 长城系列 (Great Wall Series)
• US-2000 Series
• 昆仑系列 (Kunlun Series)
• CA Series
• SL Series
• URIT Health Club

Products and services

• Urine Analysis Systems Automated urine analysis systems using AI deep learning for sediment recognition, dry chemistry analysis, and high-throughput urine testing for hospital clinical laboratories.
• US-1000 Series Automated Urine Analysis System Automated urine analysis system using AI and deep learning for rapid intelligent identification of urine formed elements with CIS scanning imaging technology.
• US-2000 Series AI Modular Urine Analysis Pipeline AI-powered modular urine analysis production line with integrated dry chemistry and sediment analysis, featuring deep learning CNN for automatic recognition of 38+ urine formed element parameters. Russia's largest public laboratory uses 8 units to process 7,000+ samples daily.
• Great Wall Series US-5000 Full Detection Chain Urine Analysis Pipeline Full detection chain urine analysis production line featuring deep learning AI for accurate identification, dual optical path system for simultaneous urine sediment and body fluid cell detection, and intelligent high-speed detection for laboratory morning rush workflows.
• US-3000 Series Urine Analysis System World's first 960T/H urine analysis system achieving full quantitative analysis of urine biochemical items.
• Blood Cell Analysis Systems Automated hematology analyzers and pipelines including the BS-7000 series (600T/H combined), BS-8000 Kunlun series blood analysis pipeline, and BH-6580 series for cell classification using sheath flow impedance and nucleic acid fluorescent staining.
• BS-7000 Series Blood Analysis Pipeline Blood analysis production line with single machine testing speed of 150T/H and combined testing speed of 600T/H, featuring nucleic acid fluorescent staining technology and RET/NRBC detection channels.
• Kunlun Series BS-8000 Blood Analysis Pipeline Blood routine, CRP, SAA joint detection blood analysis production line with integrated slide making, reading, and sample processing modules.
• BH-6580 Series Automated Hematology Analyzer Automated hematology analyzer using sheath flow impedance technology combined with semiconductor laser and flow cytometry with nucleic acid fluorescent staining for cell classification.
• Biochemical Immunoassay Systems Fully automated biochemical analyzers including CA-2000 series (1600T/H pure biochemistry, expandable to 6400T/H), URIT-8300, and CA-431C for hospital clinical biochemistry testing. URIT biochemical analyzer series ranked #2 in domestic market share for 2024-2025.
• CA-431C Automated Biochemical Analyzer Emergency-capable automated biochemical analyzer with 80 reagent positions (expandable to 120), 84 simultaneous analysis items, and 430T/H testing speed for hospital clinical biochemistry.
• PD-92 Dry Biochemical Analyzer (POCT) Dry biochemical analyzer for rapid point-of-care testing, providing 110-second ALT/AST results with laboratory-level precision from 25μL fingertip blood.
• Veterinary Diagnostics Veterinary-specific IVD analyzers including US-500Vet automated urine analyzer with animal-specific reference ranges and CA-810CVet automated biochemical analyzer (800T/H) supporting multi-species testing for veterinary clinics and research institutions.
• Flow Cytometry Systems Flow cytometers including BF-730 (three-laser, 14-color configuration with fiber optic conduction and modular spectral design), BF-710, and BF-700 (dual laser, 4-8 fluorescence channels) for clinical and research flow cytometry applications.
• Immune and Gene Diagnostic Reagents Molecular diagnostic reagents including NGS library prep kits (FFPE-direct, compatible with Ion Torrent and Illumina), PCR master mixes (GTX, TaqMan Real-Time), and Sanger sequencing chemistry (SenseCare BigDye-compatible kits, POP polymers, Hi-Di Formamide) for gene detection and sequencing applications.
• Pathology Diagnosis Systems Automated pathology staining equipment including MS-9300 and MS-3000 HE stainers featuring original SBS step-by-step slide transmission structure for delicate, high-throughput automated staining.
• SL-1000 Series Automated Vaginal Secretion Analysis System Fully automated gynecological diagnostic system combining functional and morphological vaginal secretion analysis with AI recognition rate exceeding 90% and detection speed ≥80 samples/hour for women's health diagnostics.
• UriLab Smart Laboratory Solution AI-powered smart laboratory solution providing intelligent audit efficiency, cost-effective equipment, and lightweight digital platform; reduces lab turnaround time by 30% and improves efficiency for grassroots and large hospital laboratories.
• URIT Laboratory Information System (LIS) Software Laboratory Information Management System software connecting various testing equipment, providing report management, quality control, critical value alerts, statistical analysis, AI-powered automated result review, and HL7-based LIS/HIS interoperability for hospital laboratory informatization.
• URIT-7200A Wall-Mounted General Diagnostic System Wall-mounted general diagnostic system for primary healthcare featuring compact design, remote and touch control, and integration of basic examination with dry in-vitro diagnostics for grassroots medical institutions.

Quantifiable outcome

• 40 devices selected in 11th batch of Excellent Domestic Medical Equipment Product Catalog (2026)
• +4 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability12 records

Feature8 records

Partnerships

Eight partnerships are on record, tiered major, minor and core.

• Oracle (甲骨文)majorStrategic or Co-development Partner · 31 January 2026URIT partnered with Oracle (World Top 500) to build an industry-education integration landmark at Suzhou Top College, establishing a new model for collaborative education between industry and academia in medical diagnostics technology.
• First Affiliated Hospital of Guangxi Medical University (广西医科大一附院)majorStrategic or Co-development Partner · 29 December 2025URIT signed agreement with First Affiliated Hospital of Guangxi Medical University for urological digital doctor system landing, targeting ASEAN market and expanding AI medical new blue ocean.
• China Inspection and Testing Society - Medical Testing BranchmajorStrategic or Co-development Partner · 1 December 2025URIT reached strategic cooperation with the Medical Testing Branch of China Inspection and Testing Academy and was honored as Vice President Unit, collaborating on standards development for AI medical testing applications.
• University of South China (南华大学)minorStrategic or Co-development Partner · 17 October 2025University of South China and URIT Group reached intention for school-enterprise collaborative education cooperation, focusing on talent cultivation and research collaboration in medical diagnostics.
• ICSH (International Council for Standardization in Hematology)coreStrategic or Co-development Partner · 28 June 2025URIT accepted as ICSH member, placing a Chinese IVD innovator at the heart of global hematology standard development. ICSH Executive Officer visited URIT facilities and praised their technical expertise and manufacturing quality control.
• Soochow University Medical College (苏医)minorStrategic or Co-development Partner · 13 April 2025URIT and Soochow University Medical College co-established IVD practical training base, with AI intelligent inspection application academic forum successfully held to promote industry-education integration.
• IFCC & ICSH (Global Standards Bodies)coreStrategic or Co-development Partner · 25 March 2025URIT partnered with IFCC and ICSH along with global top hospitals for international standard co-development, launching global cooperation initiative to establish shared standards for hematology testing worldwide.
• Guilin Electronic Technology University (桂林电子科技大学)minorStrategic or Co-development PartnerUniversity collaboration for talent development and AI research in medical diagnostics; Chen Hongbo, Dean of School of Life and Environmental Sciences, participated in 2019 IVD intelligentization seminar.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Emerging players

• Zybio (Chongqing Zhongyuanhuiji Biomedical): Rising Chinese IVD player with overlapping product lines in clinical chemistry, microbiology, and POCT. Zybio is a relevant emerging competitor in the same domestic and emerging-market segments URIT targets.

Direct peers

• Maccura Biotechnology: Chinese IVD peer with overlapping clinical chemistry, chemiluminescence immunoassay, and hematology offerings, listed on Shanghai Stock Exchange. Maccura is a relevant mid-cap comparable for URIT's biochemistry, immunology, and POCT segments.
• Mindray (Shenzhen Mindray Bio-Medical Electronics): China's largest domestic IVD and patient monitoring manufacturer, directly competing with URIT across hematology, clinical chemistry, and urinalysis. Both target Chinese Grade 2+ hospitals and global emerging markets, making Mindray the most direct large-cap comparable and a key share benchmark.
• Dirui Industrial (Jilin Dirui Medical Technology): A leading Chinese IVD company historically focused on urinalysis analyzers and reagents, directly overlapping with URIT's US-2000, US-3000, and US-5000 product lines. Dirui is the closest like-for-like domestic peer and the primary head-to-head competitor in Chinese hospital urine analysis tenders.
• Boule Medical (Boulediagnostics): Swedish-listed IVD company focused exclusively on hematology reagents and instruments. Boule is a relevant focused-comparable for URIT's BS-7000/BS-8000 hematology pipeline and a typical peer for emerging-market distribution economics.
• Sysmex Corporation: Global leader in hematology and urinalysis, including flow cytometry. Sysmex competes directly with URIT's BS-series and BH-series hematology analyzers, BF-series flow cytometers, and US-series urine systems, and is the global incumbent URIT is most often benchmarked against in international tenders.
• Snibe (Shenzhen New Industries Biomedical Engineering): China's leading chemiluminescence immunoassay specialist. Snibe's MAGLUMI series is the dominant domestic CLIA platform and competes with URIT's IA-260 immunoassay analyzer in the same Chinese hospital chemistry/immunoassay market.

Broad incumbents

• Roche Diagnostics: The global #1 in clinical chemistry/immunoassay with cobas systems used in most Chinese Grade 3 hospitals. Roche is the primary competitor URIT is targeting for displacement under China's import-substitution policy in biochemistry and immunoassay.
• Beckman Coulter (Danaher): Global IVD incumbent in hematology, urinalysis, and clinical chemistry, owned by Danaher. Beckman Coulter's urinalysis iQ-Series and DxH hematology analyzers compete head-to-head with URIT in international markets and represents the type of multinational incumbent URIT aims to displace.
• Abbott Diagnostics: Global IVD incumbent with ARCHITECT and Alinity series in clinical chemistry/immunoassay. Abbott is a key global incumbent URIT competes against for emerging-market hospital accounts outside China.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about URIT